P039-1839 Screening compound: N-(3-chlorophenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide

P039-1839 Screening compound: N-(3-chlorophenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide
P039-1839 Screening compound: N-(3-chlorophenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P039-1839
N-(3-chlorophenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P039-1839

Molecular Formula

C19H15ClN6O3 (C19 H15 ClN6 O3)

Compound Name

N-(3-chlorophenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide

IUPAC name

N-(3-chlorophenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]-1456-tetrahydropyridazin-1-yl}acetamide

SMILES

O=C(CN(C(CC1)=O)N=C1c1nc(-c2ccncc2)no1)Nc1cccc(Cl)c1

InChI

InChI=1S/C19H15ClN6O3/c20-13-2-1-3-14(10-13)22-16(27)11-26-17(28)5-4-15(24-26)19-23-18(25-29-19)12-6-8-21-9-7-12/h1-3,6-10H,4-5,11H2,(H,22,27)

InChI Key

XHYQKHNRJGEFDL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27559853

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.82

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.578

Distribution Coefficient, logD

2.578

Water Solubility, LogSw

-3.47

Polar Surface Area

92.802

Acid Dissociation Constant (pKa)

11.03

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.80

P039-1839 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P039-1839 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P039-1839?
Check Price and Availability of P039-1839, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P039-1839 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P039-1839
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P039-1839
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P039-1839 available by request